Gastroesophageal Reflux and Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) remains a significant global health challenge due to its chronic nature and the limitations and/or controversies of traditional management strategies, such as long-term proton pump inhibitor (PPI) use and classic fundoplication. This review has highlighted the evolution of alternative GERD treatment, showcasing a spectrum of innovative approaches that bridge the gap between conventional pharmacological management and standard surgical approaches.Empirical trial of PPI therapy is not recommended in infants and young children. Acid suppression with H2RAs or PPI should be started in children not responding to conservative management while paying attention to adverse effects. Anti-reflux surgery is not a panacea because of its potential complications, so should be indicated for those with, anatomical abnormalities or those who develop ALTE.

Autorentext
Dr. Rehab Selim Moustafa, Ph.D in Child Hood Studies Faculty of postgraduate Child Hood Studies , Ain Shams University, Assistant Professor of Child Health, National Research Centre, Egypt , Experienced in Child Health and Nutrition . Have a lot of international researches, Member in International Societies, Reviewer and editor in many journals.